PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer

Thumbnail
View/ Open

Show full item record

Author
McCubrey, James A.
URI
http://hdl.handle.net/10342/9643
Subject
 PTEN; MEK and mTOR inhibition; cancer 
Date
2017-02-21
Citation:
APA:
McCubrey, James A.. (February 2017). PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer. Scientific Reports, (43013. Retrieved from http://hdl.handle.net/10342/9643

Display/Hide MLA, Chicago and APA citation formats.

MLA:
McCubrey, James A.. "PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer". Scientific Reports. . (43013.), February 2017. May 17, 2022. http://hdl.handle.net/10342/9643.
Chicago:
McCubrey, James A., "PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer," Scientific Reports 7, no. (February 2017), http://hdl.handle.net/10342/9643 (accessed May 17, 2022).
AMA:
McCubrey, James A.. PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer. Scientific Reports. February 2017; 7() 43013. http://hdl.handle.net/10342/9643. Accessed May 17, 2022.
Collections